Skip to content
Politically.com Search all
Menu

Maryland 2026

SB 435

Public Health - Medetomidine and Xylazine Consumer Protection Act

Source: Open States / PluralUpdated 2026-11-09 10:11:02 UTC.

Official record

Measure details

Jurisdiction
Maryland
Session
2026
Chamber
upper
Classification
bill
Subjects
Age, Comptroller, Consumer Protection, Controlled Dangerous Substances, Drugs, Health, Health, Department of, Identification, Penalties and Sentences, Public Health, Records, Retail Sales, Revenue and Taxes, Rules and Regulations, Scientific Research, Substance Abuse, Veterinarians, Wholesale Distribution
Introduced / first action
2026-01-30 00:00:00

Sponsors

Source-supplied history

Actions

  1. Motion Laid Over (Senator Ready) Adopted

  2. Favorable with Amendments {

    committee-passage-favorable
  3. Favorable with Amendments Report by Finance

    committee-passage-favorable
  4. Hearing 2/11 at 2:00 p.m.

  5. First Reading Finance

    referral-committee

Recorded votes

Roll calls

No recorded vote is supplied for this bill.

When supplied by the API

Related measures